Spark Biopharma
Clinical trials sponsored by Spark Biopharma, explained in plain language.
-
New hope for advanced cancer patients after standard treatments fail
Disease control Recruiting nowThis early-stage trial is testing a new drug called SB17170 in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find the safest and most effective dose and to check for early signs that the drug might help shrink tumors.…
Phase: PHASE1 • Sponsor: SPARK Biopharma • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New hope for scarred lungs: experimental drug enters patient testing
Disease control Recruiting nowThis study is testing a new oral drug called SB17170 for people with idiopathic pulmonary fibrosis (IPF), a serious lung-scarring disease. About 30 patients will take either the drug or a placebo pill daily for 12 weeks to see if it helps slow the decline in lung function and imp…
Phase: PHASE2 • Sponsor: SPARK Biopharma • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC